Immediate Impact
25 standout
Citing Papers
Advances in targeting histone deacetylase for treatment of solid tumors
2024 Standout
Cancer epigenetics: from laboratory studies and clinical trials to precision medicine
2024 Standout
Works of Ann‐Sofie Forslund being referenced
Phase II multicentre trial of oral quisinostat, a histone deacetylase inhibitor, in patients with previously treated stage IB – IVA mycosis fungoides/Sézary syndrome
2016
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Ann‐Sofie Forslund | 80 | 38 | 9 | 36 | 10 | 166 | |
| Romina Wahab | 42 | 27 | 4 | 72 | 9 | 258 | |
| Sarah Larrigan | 31 | 41 | 3 | 59 | 10 | 236 | |
| Reeta Barua | 34 | 32 | 6 | 30 | 14 | 299 | |
| May M. Lee | 16 | 10 | 3 | 12 | 13 | 149 | |
| Pradeep Khanna | 34 | 12 | 2 | 12 | 10 | 199 | |
| Kathryn Ritchie | 12 | 18 | 3 | 86 | 12 | 264 | |
| Thomas J Kallstrom | 45 | 13 | 12 | 7 | 10 | 244 | |
| C. Havel | 35 | 21 | 12 | 36 | 8 | 215 | |
| Anne Møller Nielsen | 193 | 30 | 48 | 18 | 12 | 253 | |
| Vanessa Martins de Oliveira | 54 | 9 | 10 | 6 | 9 | 148 |
All Works
Login with ORCID to disown or claim papers
Loading papers...